The global induced pluripotent stem cells market size is calculated at USD 2.13 billion in 2025 and is expected to reach ...

World-renowned stem cell scientists will gather in Kyoto, Japan for the International Society for Stem Cell Research (ISSCR) ...

Racial disparities in mortality are increasing. This article explores how the production of DNA-edited ethnically diverse ...

This is especially problematic in cases of blocked blood vessels, which can repeatedly starve large areas of the heart of ...

the researchers describe a method of growing heart tissue from stem cells known as induced pluripotent stem cells (iPSCs). Scientists create these stem cells by gathering normal adult cells and then ...

Fate Therapeutics uses iPSC and gene editing to offer scalable off-the-shelf therapies. Read more to see why I rate FATE ...

A fully-automated bioreactor to culture human-induced pluripotent stem cells (hiPSCs) long-term has been developed by researchers at the Fraunhofer Translational Center for Regenerative Therapies.

Many labs already generate patient-derived induced pluripotent stem cells (iPSCs), but the process currently takes up to a year and costs between $5,000 and $10,000 per patient. The paper ...

Researchers have developed engineered heart muscle allografts from stem cells, showing promising results in repairing heart damage in primates and humans.

Conventional human pluripotent stem cells at the primed pluripotent state are capable of generating all the embryonic ...